Metglib Tablet

Analogous to the solitary Glipizide, yet amalgamated with Metformin, this synthesis offers twin frameworks for blood sugar regulation in type 2 diabetes. Glipizide triggers insulin discharge, while Metformin diminishes glucose formation.

• Adhere to your physicians' instructions for this medication, consuming it in the stipulated quantity and period.
• You can ingest this medication with or without a meal, however ensuring a uniform time each day is suggested for optimal outcomes.
• Ingest the medication in its entirety; refrain from masticating, pulverizing, or fragmenting it.

• Glipizide enhances insulin release, which can lead to hypoglycaemia (low blood sugar). The risk of hypoglycaemia is higher with higher doses of glipizide. Patients should be educated about recognizing the signs and symptoms of hypoglycaemia, and blood glucose levels should be monitored regularly. Dosage adjustments or changes in diet may be necessary to manage hypoglycaemia.
• Glipizide belongs to the sulfonylurea class, and individuals with a known sulpha allergy should use glipizide with caution. Cross reactivity with sulpha antibiotics is rare, but it's still important to be aware of the possibility.
• Both glipizide and metformin can cause gastrointestinal side effects, including nausea and diarrhoea. These effects may be more pronounced when the two medications are used together. Inform healthcare providers about any persistent or severe gastrointestinal symptoms.

• Manages blood sugar levels Enhances insulin sensitivity. Reduces glucose production Supports overall glycaemic control.

• Dizziness
• Diarrhea
• Nervousness
• Tremors
• Hypoglycemia (low blood glucose level)
• Flatulence
• Headache
• Nausea
• Vomiting
• Weight gain
• Abdominal discomfort
• Abnormal sensation